PREVOST G.
- Country
- France
- Department
- 2419: Endocrinology
Research Overview
- Inclisiran for Prevention of Major Adverse Cardiovascular Events in High-Risk Primary Prevention Patients with Atherosclerotic Cardiovascular Disease
- Evaluation of Domperidone on Glycemic Control in Asymptomatic Type 1 Diabetic Patients with Delayed Gastric Emptying
- Evaluation of Autologous Adipose Tissue-Derived Stromal Vascular Fraction Cells in Refractory Diabetic Foot Ulcers: A Phase II Multicenter Study
Data & Insights
Has run more than one trial at 370 of 654 partner sites.
Specializations
Cardiovascular Disease Prevention
The investigator specializes in primary prevention of atherosclerotic cardiovascular disease, with particular focus on innovative therapeutic approaches for high-risk patients.
- Major Adverse Cardiovascular Events Prevention
- Cardiovascular Risk Management
- Preventive Cardiology
Clinical expertise extends to evaluating interventions for reducing the risk of cardiovascular death, non-fatal myocardial infarction, and non-fatal ischemic stroke.
Interventional Cardiology
The investigator focuses on assessing therapeutic strategies related to urgent coronary revascularization and cardiovascular interventions in preventive medicine.
- Coronary Disease Management
- Preventive Interventions
- High-Risk Patient Care
Research activities center on evaluating modern therapeutic approaches in primary cardiovascular disease prevention.
Clinical Research Methodology
The investigator conducts randomized, double-blind, placebo-controlled multicenter studies in cardiovascular medicine.
- Cardiovascular Clinical Trials
- Preventive Medicine Research
- Therapeutic Evaluation Studies
Expertise includes designing and implementing rigorous clinical trials for cardiovascular disease prevention.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.